by Paul Noland | Feb 1, 2021 | Publications
The life sciences industry is the most promising sector of the U.S. economy, having already yielded important breakthroughs in genomics, cell and gene therapies and gene editing, to name just a few. The coronavirus crisis has only accelerated interest in this space as...